FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly'

LLY: Eli Lilly and Company
2020-06-15 22:21:00
FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
Beyond Technical Analysis

Declinazione di responsabilità